PulseAugur
EN
LIVE 22:56:09
ENTITY METiS TechBio

METiS TechBio

PulseAugur coverage of METiS TechBio — every cluster mentioning METiS TechBio across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
0
3 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
  1. 2026-06-06 funding METiS TechBio raised US$269.5 million through its IPO in Hong Kong. source
  2. 2026-05-13 funding METiS TechBio raised HK$2.11 billion (US$269.5 million) through its IPO on the Hong Kong stock market. source
RECENT · PAGE 1/1 · 3 TOTAL
  1. RESEARCH · CL_121904 ·

    China's AI drug design firms secure $75B in deals amid US scrutiny

    Chinese AI-driven drug design companies are experiencing a surge in global dealmaking, with out-licensing deals valued at $75 billion in the first five months of 2026. This represents a significant increase from pre-202…
  2. RESEARCH · CL_74228 ·

    AI accelerates biotech race to reverse aging in $610B longevity market

    Biotech firms are increasingly leveraging AI to target the burgeoning US$610 billion longevity market, aiming to reverse or slow the aging process. Companies like METiS TechBio are using AI algorithms for drug delivery …
  3. RESEARCH · CL_29492 ·

    METiS TechBio debuts on Hong Kong stock market with AI-driven drug delivery tech

    METiS TechBio, a Hong Kong-listed biotech firm, has successfully debuted on the stock market, with its shares surging significantly on its first day of trading. The company utilizes artificial intelligence to design and…